Amgen (AMGN) has seen significant stock activity recently, with members of Congress trading the stock 10 times in the last six months—seven purchases and three sales. Additionally, Amgen insiders conducted 10 trades, all of which were sales, totaling over $23 million in shares sold.
In institutional investing, 1,304 investors added shares while 1,322 reduced their positions during the latest quarter. Notably, Capital World Investors increased their holdings by 157.1% with an addition of over 10 million shares. Meanwhile, Wall Street analysts have issued a median price target of $315.0 for AMGN over the past six months, with various analysts issuing buy and sell ratings.
